Cardiovascular Research Advance Access originally published online on September 24, 2008
Cardiovascular Research 2009 81(1):98-107; doi:10.1093/cvr/cvn264
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR
in cardiac fibroblasts


Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Peoples Republic of China
* Corresponding author. Tel: +86 27 85726360; fax: +86 27 85756636. E-mail address: huangkai1{at}yahoo.com
Aims: Our aim was to explore the mechanism underlying the transcriptional regulation of adiponectin and its receptors (AdipoR) in cultured rat cardiac fibroblasts.
Methods and results: Using western blot and real-time RT–PCR assays, the expression of adiponectin and its receptors was determined. Using Southwestern blot and electrophoretic mobility shift assays, the DNA binding activity of peroxisome proliferator activated receptor
(PPAR
) was determined. The results showed that adiponectin and AdipoR1 were highly expressed in cultured rat cardiac fibroblasts. Inhibition of poly(ADP-ribose) polymerase 1 (PARP-1) by 3-aminobenzamide, PJ34, or PARP-1 siRNA markedly increased the transcription of adiponectin and AdipoR1 in cultured fibroblasts, mature 3T3 L1 adipocytes, rat myocardium, and white adipose tissue. PPAR
was poly(ADP-ribosyl)ated by PARP-1 in cardiac fibroblasts under basal conditions. Poly(ADP-ribosyl)ation of PPAR
prevented its binding to DNA. Inhibition of PARP-1 enhanced the DNA binding and transactivation of PPAR
and increased the transcription of PPAR
-target genes including CD36, lipoprotein lipase, and leptin in cultured fibroblasts.
Conclusion: PARP-1 inhibits adiponectin and AdipoR1 expression as well as PPAR
transactivation through poly(ADP-ribosyl)ation of PPAR
in cultured rat cardiac fibroblasts.
KEYWORDS Adiponectin; Poly(ADP-ribose) polymerase; Peroxisome proliferator activated receptor-gamma; Cardiac fibroblast; Transcriptional regulation
Time for primary review: 24 days
These authors have contributed equally.